IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $22,000 | +22.2% | 500 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $18,000 | -10.0% | 500 | -11.2% | 0.01% | 0.0% |
| Q1 2022 | $20,000 | +17.6% | 563 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $17,000 | +6.2% | 563 | +12.6% | 0.00% | 0.0% |
| Q3 2021 | $16,000 | -15.8% | 500 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $19,000 | -13.6% | 500 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $22,000 | -21.4% | 500 | 0.0% | 0.01% | -33.3% |
| Q4 2020 | $28,000 | +21.7% | 500 | 0.0% | 0.01% | +12.5% |
| Q3 2020 | $23,000 | -23.3% | 500 | 0.0% | 0.01% | -27.3% |
| Q2 2020 | $30,000 | +30.4% | 500 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $23,000 | -23.3% | 500 | 0.0% | 0.01% | +10.0% |
| Q4 2019 | $30,000 | +7.1% | 500 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $28,000 | -12.5% | 500 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $32,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |